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ABSTRACT 
 
Elizabeth A. Walz: The Effect of Estrogen on Inflammatory Markers Following 
Prolonged Aerobic Exercise in Eumenorrheic Women 
(Under the direction of Anthony C. Hackney) 
 
The study purpose was to determine if estrogen (E2) concentrations attenuate 
inflammation after exercise-induced muscle damage. Blood responses of pro-
inflammatory cytokine biomarker TNF-, and pro- and anti-inflammatory cytokine 
biomarker IL-6 were measured. Ten, eumenorrheic, endurance-trained women 
(Mean±SD; 21±1 years, 24.1±2.8 body fat%) were studied. They completed a 60 minute 
running protocol at ~60-65% of their oxygen uptake (VO2peak 53.5±4.7ml/kg/min) during 
two hormonal conditions (low E2 and high E2). Inflammation was assessed at rest, 
immediately post exercise, 30 minutes post exercise, and 24 hours post exercise. There 
was not a significant interaction effect for TNF- (p=0.60). There was a significant 
interaction effect for IL-6 (p=0.001).  The response at 30 minutes post exercise was 
significantly elevated from rest and significantly reduced in high E2. Results suggest high 
E2 conditions attenuate the IL-6 response.  Due to the pro- and anti-inflammatory 
influence of IL-6, it is unclear whether this attenuation is positive or negative.    
 iv 
 
 
ACKNOWLEDGEMENTS 
 I am very appreciative of the efforts of Dr. Anthony C. Hackney for helping me 
accomplish this project. I am grateful for his encouragement, guidance, and knowledge.  
Thank you to my committee members for their efforts, reviewing my work and giving me 
valuable feedback.  I am in debt to my subjects; I am so grateful they volunteered to take 
part in my thesis and I thank them for their time.  Thank you to Michelle, Timmons, 
Colin, and Amy for helping me with data collection; this was truly a team effort! 
  
 v 
 
 
 
TABLE OF CONTENTS 
 
PAGE 
LIST OF TABLES .......................................................................................................... ix 
LIST OF FIGURES .......................................................................................................... x 
CHAPTER I: INTRODUCTION ......................................................................................... 1 
Basis For Study: ......................................................................................................................................... 1 
Purpose ......................................................................................................................................................... 5 
Research Hypothesis ............................................................................................................................... 5 
Definition of terms ................................................................................................................................... 5 
Delayed Onset Muscle Soreness (DOMS) ............................................................................... 6 
Estrogen (E2) ...................................................................................................................................... 6 
Eumenorrhea ..................................................................................................................................... 6 
Moderate intensity prolonged exercise bout ....................................................................... 6 
Inflammatory Response ................................................................................................................ 7 
Delimitations .............................................................................................................................................. 7 
Limitations ................................................................................................................................................... 8 
Significance of study ................................................................................................................................ 8 
CHAPTER II: REVIEW OF LITERATURE ............................................................................ 9 
Antioxidant, membrane stabilizing and gene regulating properties of E2: ....................... 9 
Antioxidant properties of E2 ........................................................................................................ 9 
Membrane stabilizing properties of E2 ................................................................................ 11 
 vi 
Gene regulating properties of E2 ............................................................................................. 11 
Estrogenic effect on exercise-induced skeletal muscle damage, inflammation and 
repair........................................................................................................................................................... 12 
Skeletal muscle damage .............................................................................................................. 12 
Acute inflammatory response .................................................................................................. 14 
Skeletal muscle repair and regeneration ............................................................................ 16 
Interaction of E2 and progesterone ....................................................................................... 17 
Role of E2 and cytokines in exercise induced muscle damage, inflammation and 
repair........................................................................................................................................................... 18 
CHAPTER III: METHODOLOGY .................................................................................... 24 
Participants .............................................................................................................................................. 24 
Instrumentation ..................................................................................................................................... 25 
Protocol ...................................................................................................................................................... 26 
Pre-Screening ................................................................................................................................... 26 
Orientation Session I ..................................................................................................................... 26 
Follow Up Blood Draws Session III and V ........................................................................... 30 
Blood Procedures ................................................................................................................................... 30 
Hematocrit ........................................................................................................................................ 30 
Hemoglobin ....................................................................................................................................... 31 
Plasma Volume Shift ..................................................................................................................... 31 
Cytokines (TNF-α and IL-6), E2 ................................................................................................ 31 
Data Analysis ........................................................................................................................................... 32 
CHAPTER IV: RESULTS ................................................................................................ 33 
Subject characteristics ......................................................................................................................... 33 
 vii 
VO2 peak testing ...................................................................................................................................... 34 
Hormonal condition determination ............................................................................................... 34 
Prolonged treadmill running bout .................................................................................................. 35 
Blood responses to prolonged exercise ........................................................................................ 37 
Tumor necrosis factor-α (TNF-α) ........................................................................................... 37 
Interleukin-6 (IL-6) ....................................................................................................................... 37 
CHAPTER V: DISCUSSION ........................................................................................... 40 
Hormonal condition determination ............................................................................................... 40 
Prolonged aerobic exercise session ............................................................................................... 41 
Blood responses ..................................................................................................................................... 42 
Tumor Necrosis Factor (TNF-α) .............................................................................................. 42 
Interleukin-6 (IL-6) ....................................................................................................................... 43 
APPENDIX A: SAMPLE SIZE CALCUATIONS .................................................................. 48 
APPENDIX B: INFORMED CONSENT ............................................................................ 49 
APPENDIX C: MEDICAL SREENING FORMS .................................................................. 56 
Physical Examination Screening ...................................................................................................... 56 
Medical History Questionnaire ........................................................................................................ 57 
APPENDIX D: ACSM METABOLIC EQUATION FOR DETERMINING EXERCISE INTENSITY .. 61 
APPENDIX E: MENSTRUAL CYCLE QUESTIONNAIRE ..................................................... 62 
APPENDIX F: FOOD LOG ............................................................................................ 63 
APPENDIX G: DATA COLLECTIONS FORM .................................................................... 64 
Orientation Session ............................................................................................................................... 64 
 viii 
Experimental Session ........................................................................................................................... 65 
Hematocrit and Hemoglobin ............................................................................................................. 66 
Subject Compliance ............................................................................................................................... 67 
APPENDIX H: ASSAY SHEETS ...................................................................................... 68 
Estrogen Assay Information .............................................................................................................. 68 
TNF- Assay Information ................................................................................................................... 69 
IL-6 Assay Information ........................................................................................................................ 72 
REFERENCES ............................................................................................................. 75 
 
  
 ix 
LIST OF TABLES 
 
Table 
1. Speed (miles per hour; mph) and grade for each three-minute stage 
of the Bruce protocol incremental exercise test………………….……………....28 
 
2. Descriptive data for subjects……………………………………………………..34 
 
3. Descriptive data (mean ± SD) for VO2, HR and RPE for each  
prolonged running bouts in each hormonal condition (LE and HE…………...…36 
 
4. Mean (± SD) plasma volume shifts from rest to immediately  
post exercise (R-IP), rest to 30 minutes post exercise (R-30P) and  
rest to 24 hours post exercise (R-24P) …………………………………………..36 
 
5. Mean (± SD) for TNF- at rest, immediately post exercise (IP),  
30 minutes post exercise (30P), and 24 hours post exercise (24P).  
An * indicates significant increase from rest, while an ^ indicates  
significant increase from IP……………………………………………...………38 
 
6. Mean (± SD) for IL-6 at rest, immediately post exercise (IP),  
30 minutes post exercise (30P), and 24 hours post exercise (24P).  
An * indicates significance from rest, an ^ indicates significantly  
lower IL-6 compared to LE, while a # indicates an interaction effect  
between hormonal condition and time…………………………………….……..39 
 
  
 x 
LIST OF FIGURES 
Figure 
1. Theoretical model illustrating the potential protective role of estrogen in  
 skeletal muscle damage, inflammation, and repair…………………………...….22 
 
2. Figure 2: A diagram showing the protocol of the experimental sessions………..30 
 
 1 
 
 
CHAPTER I 
 INTRODUCTION 
 
Basis For Study: 
 There has been debate surrounding the influence of 17-estradiol (E2) on skeletal 
muscle, and whether E2 has a protective influence on skeletal muscle damage, 
inflammation, and repair after prolonged aerobic exercise. This area of research is limited.  
There are multiple studies indicating that high levels of E2 attenuate circulating cytokines, 
and as a result attenuate inflammation during non-exercise induced inflammatory 
responses (Pfeilschifter et al., 2002; Pottratz et al., 1994; Puder et al., 2001; Schwarz et 
al., 2000).  This indicates that there may be a similar phenomenon occurring during 
exercise induced inflammatory responses. A clear relationship between E2 and 
inflammation after exercise induced muscle damage, in women, is not well defined in 
existing literature. Some studies suggest there is an estrogenic effect on circulating 
cytokines, while other do not (Dieli-Conwright et al., 2009; Ives et al., 2011; Timmons et 
al., 2005; Timmons et al., 2006).  These conflicting results may be due to study 
limitations, such as small sample sizes, lack of a treatment condition, or inadequate 
exercise stimuli (Ives et al., 2011).  The intent of the current study was to overcome these 
limitations, with sufficient power, a treatment condition, and adequate exercise stimulus.  
Unfortunately, due to the difficulty of recruiting subjects, the study was underpowered 
for TNF- (β= 0.65).  Evaluating the influence of E2 fluctuations across the menstrual 
cycle, and how this impacts skeletal muscle, will add to this body of knowledge, and is an 
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important consideration for women designing training programs to improve performance 
and minimize risk. 
E2 is a steroid hormone-molecule that plays an important role in maintaining and 
regulating sexual and reproductive function in females.  Additionally, E2 exerts an 
influence on other physiological systems in females, such as the cardiovascular, 
musculoskeletal, immune and central nervous systems.  The form of E2 that has the 
largest effect on these systems is 17β-estradiol (Enns & Tiidus, 2010). There are three 
mechanisms by which E2 might exert a protective effect on skeletal muscle damage, 
inflammation, and repair. E2 may act as an antioxidant, membrane stabilizer, and gene 
regulator (Perskey et al., 1999).  Similar to other antioxidants with similar structures, it 
has been suggested that the phenolic hydroxyl group on E2 donates a hydrogen atom 
which disrupts free radical damaging cascades, minimizes lipid peroxidation and thus 
limits cell membrane damage (Perksy et al., 1999; Sugioka et al., 1987).  E2 may also 
stabilize membranes by intercalating with membrane phospholipids, similar to cholesterol 
(Perksy et al., 1999).  Finally E2 may also exert protective effects through gene regulation, 
affecting cytokine and cell-adhesion activity, as well as activation of satellite cells (Smith 
et al., 2000; Enns et al., 2008; Enns & Tiidus, 2008).  With these protective properties, E2 
may attenuate exercise-induced muscle damage, and inflammation while also facilitating 
repair in skeletal muscle.   
While exercise-induced oxidative stress and membrane damage are important 
signals for the skeletal muscle tissue to adapt, there are potential negative side-effects, 
such as reduced muscle strength, muscle soreness, and increased creatine kinase, as well 
as increased β-glucoronidase activity and histologic damage of the cell (Clarkson et al., 
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2001; Komulainen et al., 1999).  E2 may play a role in decreasing the severity of these 
side-effects during high intensity exercise (Bar et al., 1988; Roth et al., 2000, 
Komulainen et al., 1999).  After exercise induced muscle damage, inflammatory 
processes are activated to clear and repair the damaged cell.  These processes include an 
infiltration of fluid, plasma proteins and circulating leukocytes, which is mediated by a 
variety of cytokines (St. Pierre Schneider et al. 1999; Tiidus et al. 2001).  The cytokines 
of interest in this study are tumor necrosis factor-alpha (TNF-α) and interleukin 6 (IL-6).  
TNF-α is considered to be a pro-inflammatory cytokine, produced to recruit more 
leukocytes to the inflamed tissues.  IL-6 has been shown to be both a pro- and anti-
inflammatory cytokine.  Until recently, researchers considered IL-6 to be a pro-
inflammatory cytokine.  For example, MacIntyre et al. (2001) reported that neutrophil 
and IL-6 increased up to 6 h post-exercise, and there was a significant relationship 
between IL-6 and DOMS, suggesting that IL-6 is a pro-inflammatory cytokine that 
initiates inflammation. It is thought that anti-inflammatory IL-6 may be released locally 
in the muscle after strenuous exercise and the amount released is dependent on the type 
of physical activity, as well as the duration of exercise (Hamer & Karageorghis 2007).  
Currently, the literature is unclear as to the exact role this cytokine plays in the 
inflammatory response (Pedersen et al., 2004; Smith et al., 2000).   
Some researchers have suggested that E2 may positively influence inflammation 
by attenuating pro-inflammatory cytokine TNF-α, reducing leukocyte activity and 
collateral damage to healthy cells, as well as initiating satellite cell activity (Tiidus et al., 
2001).  Satellite cells activation initiates cell growth and repair.  An estrogenic effect on 
satellite cell activation was shown by Roth et al. (2001) where resistance trained women 
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displayed a greater increase in satellite cell number when compared to men.  Additionally, 
Enns et al. (2008) demonstrated that satellite cell activity increased in E2 supplemented, 
exercised rats compared to other controls.  The Enns study also suggests that E2 may 
increase satellite cell activation through receptor-mediated mechanisms (Enns et al., 
2008).   As evidenced here, there are strong reasons to believe that E2 exerts a protective 
effect on exercise induced muscle damage, inflammation, and repair. 
The present study focused on inflammatory mechanisms after exercise induced 
skeletal muscle damage; specifically the effect of E2 on inflammatory markers, TNF-α 
and IL-6. Since IL-6 has been shown to have both anti- and pro-inflammatory properties, 
it is not primary variable of interest.  It was included to add to investigations previously 
produced from this research group.  This particular study focused on the effect of E2 on 
TNF-α during the inflammatory response after an exercise induced muscle damage bout.  
Ostrowski et al. (1999) reported that strenuous exercise increased concentrations of TNF-
α.  Chao et al. (1995) found that TNF-α fluctuated with changes in estrogen 
concentrations.  Additionally Schwarz et al. (2000) found that the release of TNF-α was 
diminished in pre-menopausal women during the luteal phase of the menstrual cycle, 
when compared to the follicular phase, which suggests an anti-inflammatory response.  
This author also found that TNF-α and IL-6 were inhibited in females, compared to male 
controls.   These studies provide evidence that there may be a relationship between E2 
and inflammatory markers.  Thus with this in mind, a key goal of the present study was to 
clarify the role of E2 on TNF-α after exercise induced muscle damage.  In this study, the 
primary outcome variable of interest was TNF-α, and the secondary variable of interest 
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was IL-6; each was assessed at four time points (at rest, immediately post-exercise, 30 
minutes post-exercise, and 24 hours post exercise).   
Purpose 
The purpose of this study was to determine if E2 levels influence pro-
inflammatory marker TNF-α following a moderate intensity exercise protocol in 
eumenorrheic women.   
A secondary purpose of this study was to determine if E2 levels influence pro- or 
anti-inflammatory cytokine IL-6 following a moderate intensity exercise protocol in 
eumenorrheic women.   
Research Hypothesis 
 If E2 is related to pro-inflammatory cytokine TNF-α, then higher E2 levels in 
eumenorrheic women will attenuate TNF-α concentrations after a moderate intensity 
exercise protocol.   
 A secondary research hypothesis is if E2 is related to pro- or anti-inflammatory 
cytokine IL-6, then higher E2 levels in eumenorrheic women will attenuate IL-6 
concentrations after a moderate intensity exercise protocol.   
Definition of terms 
Cytokines 
 Cytokines are released in response to stress, infection, illness and inflammation, 
as part of the innate immune response of the human body.  Cytokines mediate immune 
responses activated in order to repair and clear damaged cells.  Cytokines can be pro- or 
anti-inflammatory (Corwin 2002; Pederson et al., 1998; Pederson et al., 2004).  
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Delayed Onset Muscle Soreness (DOMS) 
 
Following high intensity exercise, muscle injury can cause myofiber damage, 
including sarcolemma disturbances, swelling or disturbances of the contractile proteins, 
cytoskeletal and extracellular matrix damage and disturbance (Kendall & Eston, 2002). 
Estrogen (E2) 
 
18-carbon steroid molecule-hormone, secreted by the ovaries in women and (to a 
much lesser extent) in the testes in men.  E2 is important in the maintenance of normal 
sexual and reproductive function in females, but also plays a role in many cardiovascular, 
musculoskeletal, immune and central nervous system functions.  E2 exists in several 
forms, the most prominent is estradiol -17, and is known to fluctuate across the 
menstrual cycle (Ruggerio & Likis 2002; Enns & Tiidus 2010). 
Eumenorrhea 
 Normal menstrual cycle, typically seen in women ages 18-30 years, in which 
cycles establish an early follicular phase increase in follicle-stimulating hormone, a pre-
ovulatory luteinizing hormone peak, a luteal phase of at least 11 days, and a progesterone 
peak greater than 10ng/mL (Sherman & Korenman, 1975).  A typical menstrual cycle 
lasts 28 days.  
Moderate intensity prolonged exercise bout 
 Exercise performed on a treadmill at 0% grade with a speed equal to ~60-65% of 
VO2max for 60 minutes.  Previous investigations from the same research group indicate 
this exercise to be a high enough intensity to elicit muscle damage (Hackney et al., 2012).  
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Inflammatory Response 
 
The inflammation process and satellite cell activation and proliferation is initiated 
by local and systemic signals, such as cytokines, growth factors and leukocytes, released 
by the injured muscle tissues (Hamer & Karageorghis, 2007).   
Leukocytes 
 During the inflammatory process after muscle damage leukocytes, such as 
neutrophils and macrophages, accomplish three tasks: breakdown damaged muscle tissue, 
remove the damaged muscle tissues, and restore function of muscle tissues (Kendall & 
Eston, 2002). 
Delimitations 
1. Participants were healthy females between the ages of 18-30 years. 
2. Participants were eumenorrheic and not currently taking oral contraceptives or other 
hormone therapy six months prior to participation in this study. 
3. Had not sustained an injury within the last six months that limited the ability to 
exercise or have a doctor’s clearance. 
4. Had not been taking anti-inflammatory medicines, such as ibuprofen, naproxen, or 
aspirin six months prior to participation in this study. 
5. Were not pregnant or become pregnant during the study. 
6. Become ill with an immune responding condition, such as a cold or respiratory 
infection during the study. 
7. Had a current minimum training volume of 3-5 days a week, 45-120 minutes per 
session of aerobic activity, and a maximal oxygen consumption (VO2 max) of at least 
45 ml/kg/min. 
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8. Abstained from strenuous physical activity and maintained a diet similar in calories 
and carbohydrate content 24 hours prior to experimental protocol. 
Limitations 
1. Results may not be applicable to men and some women (amenorrheic, 
oligomenorrheic, or post-menopausal).  
2. Subjects may not comply with specific pre-test instructions. 
3. Cytokine concentrations will be measured in blood, there will not be another method 
to verify local cytokine changes (such as muscle messenger RNA [mRNA]). 
Significance of study 
 Understanding the influence of E2 on the inflammatory response following muscle 
damage is an important consideration for both women and researchers.  Women who 
experience amenorrhea or are post-menopause may be missing the potential protective 
influence of E2 related to muscle damage, inflammation, and repair. Additionally women 
who are eumenorrheic would benefit from knowing the potential protective properties of 
estrogen.  This information could be used to design training programs that optimize 
performance and minimize risk, such as periodization of training based on hormonal 
condition.  While there are many important training considerations for understanding 
estrogenic influence, it is especially crucial to account for estrogenic influence when it 
comes to designing research studies involving women. Failing to account for hormonal 
fluctuations throughout the menstrual cycle may affect the results of these studies.  Lastly, 
research in this area is limited and results are contradictory.  More research needs to be 
done in this area to clarify the role of E2 on the inflammatory response after exercise-
induced muscle damage. 
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CHAPTER II 
REVIEW OF LITERATURE 
 
In this review, the influence of E2 on skeletal muscle damage, inflammation, and 
repair will be examined.  There are three potential mechanisms by which E2 exerts a 
protective effect on skeletal muscle. E2 may act as an antioxidant, membrane stabilizer, 
and gene regulator (Kendall & Eston, 2002; Enns and Tiidus, 2010).  It is a well-
documented phenomenon that muscle damage occurs after strenuous, unaccustomed 
exercise (Clarkson et al., 2001).  Following exercise-induced skeletal muscle damage, 
pro- and anti-inflammatory cytokines and other chemo-attractants facilitate inflammation 
and repair.   This response involves the recruitment of leukocytes, such as neutrophils and 
macrophages, and the activation and proliferation of satellite cells (Belcastro et al., 1998).   
This review will discuss how E2 exerts protective mechanisms on skeletal muscle, the 
effect of E2 on pro-inflammatory cytokine TNF-, and the pro- or anti-inflammatory 
cytokine IL-6 after exercise-induced muscle damage. 
 
Antioxidant, membrane stabilizing and gene regulating properties of E2: 
Antioxidant properties of E2 
 
It is well known that during strenuous exercise oxygen consumption increases to 
meet metabolic demand.  With this increase in oxygen consumption, there is a similar 
increase in free radical production.  It is estimated that with every 25 oxygen molecules 
 10 
reduced by oxidative metabolism, there is one free radical produced (Kanter 1998).  Thus 
oxygen free radicals may rapidly accumulate during strenuous exercise and result in 
oxidative damage, production of reactive oxygen species (ROS), and lipid peroxidation, 
all of which alter membrane fluidity and cell membrane stability (Sen 1995).  In addition 
to free radicals produced during oxidative metabolism, free radicals can be produced as a 
result of enzyme activity with the recruitment of neutrophils in the inflammatory 
response (Fantone et al., 1982).   There is a link between excess free radicals, due to 
either over-production or a decrease in the effectiveness of antioxidants, and developing 
diseases, such as cancer, atherosclerosis, and Alzheimer’s (Persky et al., 1999). 
Endogenous production of antioxidants, such as E2, serves to protect skeletal cell 
membranes from free radical damage.  More specifically, the phenolic hydroxyl group on 
estrogen donates a hydrogen atom to disrupt free radical damaging cascades, minimize 
lipid peroxidation and thus limit cell membrane damage (Perksy et al., 1999; Sugioka et 
al., 1987).  Both E2 status in females and intensity of exercise affect lipid peroxidation.  
Ayers et al (1998) evaluated the difference between eumenorrheic (measured during high 
E2) and amenorrheic athletes’ responses to exercise-induced oxidative stress.  These 
authors found that there was a greater potential for lipid peroxidation after 15 minutes of 
maximal treadmill exercise for amenorrheic athletes when compared to eumenorrheic 
athletes.  Additionally, Feng et al. (2004) found that physiological levels of E2 could 
increase membrane stability, reduce consumption of glutathione (GSH) and Vitamin E 
(both of which are antioxidants), and maintain overall antioxidant capability of the 
strained muscles in female rats.  Additionally the results showed that there was decreased 
muscle injury and increased muscle regeneration after an acute strain injury in female rats.  
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These studies highlight how skeletal muscle cells might be susceptible to free radical 
damage and how E2 may exert protective effects through direct antioxidant actions.   
Membrane stabilizing properties of E2 
 
E2 may also be able to exert protective effects through membrane stabilizing 
mechanisms.  The ability of fat-soluble E2 to interact with phospholipids also contributes 
to the membrane stabilizing properties of E2, similar to cholesterol (Whiting et al., 2000).  
Whiting et al. (2000) studied the effect of testosterone, progesterone, and E2 on various 
liposomes, plasma membranes, and sarcoplasmic reticulum membranes.  This group 
suggests that E2 has the ability to intercalate with phospholipids, alter the fluidity of 
phospholipids, and increase protein mobility in membrane bilayers, all of which may 
affect protein function.  Although the authors in this study found E2 to increase 
membrane fluidity, they demonstrated a mechanism by which steroid hormones influence 
these actions.  Multiple researchers have suggested the opposite, that E2 decreases 
membrane fluidity and stabilizes membrane phospholipids due to its structure and 
antioxidant ability (Kendall & Eston 2002; Persky et al., 1999).  Nonetheless, E2 may 
play an important role in the stabilization of skeletal cell membranes and the conflicting 
findings show the need for further research in this area.   
Gene regulating properties of E2 
 
Lastly, E2 may potentially exert protective effects on skeletal muscle through gene 
regulation.  Gene regulation by E2 may affect cytokine and cell adhesion activity, as well 
as the activation of satellite cells.   Research involving another known antioxidant, 
tocopherol, has shown that tocopherol regulates nuclear factor kappa B, which is a 
regulator of cytokines and cell adhesion molecules.  Yoshikawa and Yoshida (2000) 
 12 
suggested that tocopherol prevents signal transduction of leukocyte-endothelial cell 
adhesion. Cytokine production and leukocyte-endothelial cell adhesion are important 
factors regulating leukocyte infiltration.  In another study Enns et al. (2008) demonstrated 
that E2 may increase muscle satellite cell numbers through E2 receptor mediated 
mechanisms, indicating upstream gene regulation of satellite cell activation.  Furthermore 
these authors suggested that the attenuation of exercise-induced muscle damage and 
leukocyte infiltration via estrogenic effects was not mediated by E2 receptor mechanisms 
(Enns et al., 2008; Enns & Tiidus, 2008).  This supports the findings by Yoshikawa and 
Yoshida, who suggested that the attenuation of exercise-induced muscle damage and 
leukocyte infiltration may be attenuated via estrogenic regulation of endothelial cell 
adhesion and leukocyte infiltration.  The ability of E2 to decrease leukocyte infiltration 
and increase satellite cell activation may be due to the gene regulating properties of E2. 
 
Estrogenic effect on exercise-induced skeletal muscle damage, inflammation and 
repair  
Skeletal muscle damage 
 
Skeletal muscle damage caused by strenuous, unaccustomed exercise can be 
measured directly or indirectly.  It can be directly measured via muscle biopsies, or 
indirectly measured through muscle strength loss, muscle soreness, and increased muscle 
proteins, such as creatine kinase (Clarkson et al., 2001).  Additionally, the protein β-
glucoronidase activity can reflect the histopathological state of the cell, which indicates if 
muscle damage results from the inflammatory response (Komulainen et al., 1999). 
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As previously mentioned, E2 may have the ability to attenuate skeletal muscle 
damage by acting as an antioxidant and membrane stabilizer.  As a result of exercise 
induced oxidative stress and membrane damage, more creatine kinase is able to permeate 
the membrane and elicit a larger inflammatory response (Bar et al., 198; Sewright, 2008, 
Roth et al., 2000).   Bar et al. (1988) suggested that E2 may have a protective effect on 
skeletal muscle damage by showing reduced creatine kinase values after exercise induced 
stress.  In a more recent study, Sewright (2008) hypothesized that there would be similar 
responses between men and women regarding indirect skeletal muscle damage markers, 
but there would be sex differences in the variability and distribution of indirect skeletal 
muscle damage markers. These authors found that women experienced greater immediate 
strength loss, while men showed greater creatine kinase activity.  These results indicate 
sex differences in fatigue and muscle damage after intense exercise.  Sex differences in 
fatigue may be due to metabolism, blood flow or intracellular calcium, while sex 
differences in muscle damage may be due to estrogenic protective mechanisms.   
Additionally, Roth et al. (2000) suggests that E2 levels in women influences the degree of 
muscle damage after heavy-resistance strength training three times a week for nine weeks.  
Muscle damage increased significantly in older women, from 5 to 17% of muscle fibers 
damaged, compared to younger women, from 2 to 5% of muscle fibers damaged.   
Taking a different approach to evaluating skeletal muscle damage differences 
between males and females, Komulainen et al. (1999) evaluated β-glucoronidase activity, 
histological assessment of muscle samples for inflammation, and immunohistochemistry 
of structural proteins of muscle fibers, such as actin, desmin, and dystrophin, and 
extracellular matrix proteins, such as fibronectin, in rats after eccentrically biased 
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downhill running exercise.  β-glucoronidase activity was smaller and histological changes 
were slower and less prominent in female rats compared to male rats.  Additionally, 
immunohistochemical changes in structural and extracellular matrix proteins were 
unchanged in female rats when compared to male rats.   
Both rodent and human studies suggest that the skeletal muscle cell membranes in 
females compared to males, are stronger and better able to resist exercise-induced 
skeletal cell membrane damage. This may be due to a protective estrogenic effect on 
skeletal muscle cells following damaging exercise.    
Acute inflammatory response  
 
To clear and repair skeletal muscle tissue after an acute bout of high intensity 
exercise there is an acute inflammatory response in which there is an increase in fluid, 
plasma proteins and circulating leukocytes.  Vascular endothelial cells, tissue-resident 
leukocytes, and circulating leukocytes produce a variety of cytokines that mediate the 
inflammatory response. For example, the up-regulation of pro-inflammatory TNF-α is 
associated with resident macrophages in the damaged muscle tissue (Smith et al., 2000).  
Interestingly IL-6 can be either pro- or anti-inflammatory, depending on how much of it 
is released or what is being released along with it.  Thus pro-inflammatory IL-6 may be 
associated with resident macrophages, while anti-inflammatory IL-6 may be associated 
with the exercising muscle tissue, specifically substrate mobilization (Pederson et al., 
2004).  There are multiple families of cytokines that play a role in regulating the acute 
inflammatory response, including; interleukins (IL), tumor necrosis factors (TNF), 
interferons, growth factors, colony stimulating factors (CSFs), and cell adhesion 
molecules (CAM) (Smith et al., 2000). While TNF-α and IL-6 are the main cytokines of 
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interest in this study, it is important to understand there are many cytokines that play a 
crucial role in inflammation.   
The infiltration of leukocytes, primarily neutrophils and macrophages, remove 
damaged muscle tissues and stimulate repair processes.  St. Pierre Schneider et al. (1999) 
induced skeletal muscle injury using an in vivo lengthening contraction model in 50 
sexually mature mice.  Leukocyte infiltration was assessed after 1, 3, 5, and 7 days of 
recovery.  While leukocytes invaded muscle fibers in both sexes after 1 day, there were 
differences in the subsets of leukocytes between the sexes.  The authors concluded that 
leukocyte activity associated with the inflammation may be prevented or delayed in 
female mice after exercise induced injury.  Both neutrophils and macrophages play a 
crucial role in removing and repairing damaged muscle tissues.  While this activity is 
necessary, excessive infiltration of leukocytes can cause an increase in muscle membrane 
and oxidative damage.  It is still unknown whether E2 enhances or hinders the 
inflammation process. E2 may positively influence inflammation by reducing leukocyte 
activity, and thus reducing oxidative damage and collateral damage to healthy cells. 
However, estrogenic influence that reduces inflammation may result in a diminished 
ability to repair damaged muscle tissue (Tiidus et al., 1999, Tiidus et al., 2001).     
With exercise induced muscle damage there are disruptions to the sarcomere Z 
line and sarcoplasmic reticulum, resulting in changes in calcium concentrations and the 
rate of protein degradation.  Calpain is a non-lysosomal cysteine protease that degrades 
the damaged cytoskeletal and myofibrillar proteins.  Protein degradation, induced by 
Calpain activity, produces peptide fragments that act as chemo-attractants to neutrophils 
(Belcastro et al., 1998).  E2 may reduce neutrophil infiltration, acting as an antioxidant 
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and membrane stabilizer, by reducing sarcomere disruption, and calcium disturbances 
(Tiidus et al., 2001).  Neutrophil activity contributes to further oxidative damage in 
muscle tissues via the production of ROS from NADPH oxidase and the production of 
hypochlorous acid from hydrogen peroxidase from the myeloperioxidase (MPO) reaction 
(Suzuki et al., 1999; Tiidus et al., 1999).  MPO activity is known as an indicator of 
neutrophil activity in damaged muscle tissue.  Tiidus et al., 1999 found there were 
significant elevations in muscle MPO activity 24 hours post exercise in male rats 
compared to female rats and estrogen supplemented male rats.  The authors suggest that 
while MPO represents neutrophil activity, infiltration of macrophages at 24 hours post 
exercise may have begun, thus MPO activity at 24 hours post exercise is indicative of 
overall leukocyte activity and inflammation.  Increasing MPO activity plays an important 
role in clearing damaged muscle tissue, but can be damaging to healthy muscle tissue.  
Further clarification in the literature will be needed in order to elucidate whether an E2 
mediated reduction in inflammation is advantageous or not. 
Skeletal muscle repair and regeneration 
 
After skeletal muscle cell damage, satellite cells are activated to proliferate and 
provide the necessary materials to initiate muscle growth and repair.  There may be an 
estrogenic effect on the activation and proliferation of satellite cells.  For example,   
resistance trained women displayed a greater increase in satellite cells when compared to 
men (Roth et al., 2001).  In another study, histochemical analysis was used to show that 
the greatest number of muscle fibers containing total, activated and proliferating satellite 
cells were in the exercised, E2 supplemented group of female rats (Enns et al., 2007), 
compared to unexercised and no estrogen rats, unexercised and E2 supplemented rats, and 
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finally exercised and no E2 rats.  E2 might increase satellite cell activation through 
receptor-mediated mechanisms.  For example, when E2 receptors are blocked or there is 
an E2 receptor antagonist, exercise and E2-mediated increases in satellite cells are 
inhibited (Enns et al., 2008).  
Another important promoter of satellite cell propagation might be the infiltration 
of leukocytes.  Even though it is hypothesized that E2 decreases the leukocyte response 
following muscle damage, new research proposes that E2 increases IL-6 levels and nitric 
oxide, which are known activators of satellite cells.  This means that E2 can both increase 
satellite cell production and proliferation and still attenuate the leukocyte response (Enns 
& Tiidus, 2010, Tiidus 2003).  The effect of E2 on the inflammatory response requires 
further research, in order to clarify E2’s role in activation of satellite cells and leukocyte 
recruitment.  As IL-6 is an important player in these mechanisms, the effect of E2 on IL-6 
levels is an important step in identifying these mechanisms.  
Interaction of E2 and progesterone 
 
 There has been limited research investigating the effects of progesterone and E2 
on exercise induced damage, inflammation and repair.  Studies involving female 
ovariectomized rats treated with E2 showed less neutrophil and macrophage infiltration in 
skeletal muscle following eccentric exercise, compared to rats not treated with E2 (Enns 
et al., 2008; Iqbal et al., 2008) The reduced inflammatory response in rats treated with E2 
may be related to reduced muscle damage as shown by reduced skeletal muscle damage 
markers, such as β-glucuronidase and creatine kinase (Enns et al., 2008).  Reduced 
skeletal muscle damage may be a result of the estrogenic muscle membrane stabilizing 
properties (Tiidus et al., 2001).  In most tissues there are both E2 receptors and 
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progesterone receptors present and there is the possibility that there are interactive effects 
in response to exercise induced muscle damage (Iqbal et al., 2008).  To investigate these 
interactive effects between E2 and progesterone, Iqbal et al., (2008), compared the 
concentrations of each hormone at 24 hours post exercise.  The female rats were divided 
into 4 exercise and 4 control groups (sham, E2, progesterone, and a combination of E2 
plus progesterone) following 8 days of hormone replacement.  They confirmed that E2 
attenuated leukocyte infiltration following exercise induced muscle damage.   They also 
found that progesterone also attenuated leukocyte infiltration, but to a smaller extent than 
E2.  In rats supplemented with both progesterone and E2, leukocyte infiltration was not 
significantly different from the E2 only group, suggesting that progesterone does not 
affect estrogenic influence.   
 
Role of E2 and cytokines in exercise induced muscle damage, inflammation and 
repair 
The acute inflammatory response and satellite cell activation and proliferation are 
initiated by local and systemic signals, such as cytokines, growth factors and leukocytes, 
released by the injured muscle tissues. In response to moderate to high intensity exercise, 
pro-inflammatory cytokines TNF-α and anti-inflammatory cytokine IL-6 are produced.  
Pro-inflammatory cytokines up-regulate leukocytes, calpains, and nitric oxide in order to 
initiate the inflammatory response at the site of tissue damage.  Anti-inflammatory 
cytokines are thought to limit the inflammatory response to exercise and inhibit pro-
inflammatory cytokines (Pedersen et al., 2003). In the inflammatory response, anti-
inflammatory IL-6 is one of the first cytokines present after high intensity exercise, and it 
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is the produced in large amounts.   As muscle damage occurs, resident leukocytes 
produce pro-inflammatory cytokine TNF-α to initiate inflammation and repair 
mechanisms.  While the inflammatory response is critical to muscle damage repair and 
regeneration, the large response affects both damaged and healthy tissues, resulting in 
more inflammation than might be needed to repair the tissue.  It is hypothesized that if E2 
plays a role in limiting the inflammatory response, less muscle damage will occur 
(Kendall & Eston, 2002).  TNF-α and IL-6 are major inflammatory markers during 
exercise induced muscle damage, inflammation and repair.  If these inflammatory 
markers are attenuated as a result of E2 in the human body, then it could be inferred that 
E2 has a protective role in limiting muscle damage and inflammation.  
 The cytokine TNF-α plays a major role in regulating the influx of leukocytes in 
clearing damaged muscle tissue and stimulating repair.  Ostrowski et al., (1999) reported 
that strenuous exercise resulted in increases in pro-inflammatory cytokine TNF-α.  In 
addition this group suggested that anti-inflammatory cytokines, such as IL-6, may restrict 
the potency and duration of the inflammatory response after exercise.  E2 has been shown 
to alter the concentration of TNF-α.  For example Chao et al., (1995) found that TNF-α 
fluctuates with changes in the E2 and progesterone.  While this is an endotoxin model, not 
an exercise model, these results suggest a relationship between E2 and TNF-α.   In 
another endotoxin model, E2 was shown to attenuate TNF-α and IL-6 in post-menopausal 
women receiving E2 replacement.  Bacterial endotoxin studies can serve as a model to 
study TNF-α and other cytokines in the acute phase response because endotoxin 
stimulates the production of cytokines and leukocytes, similar to the response seen during 
exercise induced muscle damage (Puder et al., 2001).   
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IL-6 is an interesting cytokine because it has been shown to have both anti- and 
pro-inflammatory properties.  It is thought that anti-inflammatory IL-6 is released locally 
in the muscle after strenuous exercise and the amount released is dependent on the type 
of physical activity, as well as the duration of exercise (Hamer & Karageorghis, 2007).  
After strenuous exercise, IL-6 is markedly increased more so than any other cytokine.  
Pederson et al., (2004) suggests that IL-6 is produced first and plays an important role in 
the inflammatory response.  Previous studies suggest that muscle damage was related to 
IL-6 production, while later studies showed that high intensity training elevated creatine 
kinase levels, but failed to increase IL-6 levels (Pederson et al., 2004). This suggests that 
IL-6 response may be independent of muscle damage; Although, this view is not held by 
all immunology researchers.  Furthermore a different study, comparing the levels of IL-6 
production in the hind legs of rodents, found that there was no difference in IL-6 
production in concentric and eccentric contractions (Jonsdottier et al., 2000).  While 
muscle damage may not be directly dependent on IL-6 levels, it has been shown that IL-6 
produced locally from the exercising muscles exerts an anti-inflammatory effect on the 
immune response.  Until recently, researchers considered IL-6 to be a pro-inflammatory 
cytokine.  For example, MacIntyre et al., (2001) reported that neutrophil and IL-6 
increased up to 6 h post-exercise, and there was a significant relationship between IL-6 
and DOMS, suggesting that IL-6 as a pro-inflammatory cytokine initiates inflammation.   
Further research needs to be completed in order to clarify the roles of pro- and anti-
inflammatory IL-6.  Due to the uncertainty of the role of IL-6, it is not the primary 
variable of interest in this study.   
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In the present study, the effects of E2 and TNF-α on muscle damage, 
inflammation and repair are being evaluated.  IL-6 is included as a secondary variable in 
this study to investigate how IL-6 affects TNF-α and if there is a relationship between E2, 
IL-6 and inflammation.  Schwarz et al (2000) found that the release of TNF-α was 
diminished in pre-menopausal females during the luteal phase of the menstrual cycle 
when compared to the follicular phase of the menstrual cycle, as well as the inhibited 
release of both TNF-α and IL-6 in females during the luteal phase when compared to 
male controls.  In a study by Pottratz et al (1994), E2 was shown to inhibit the expression 
of the IL-6 gene through an E2 receptor mediated effect on the transcription of the gene’s 
promoter region.  Due to the unclear pro- or anti-inflammatory cytokine properties, IL-6 
is hard cytokine to measure and accurately describe its effect on physiological systems 
related to muscle damage and inflammation.  Thus TNF-α is the primary inflammatory 
marker measured in this study, because it is a known pro-inflammatory cytokine marker 
and its effect on physiological systems related to exercise induced skeletal muscle 
damage, inflammation and repair can be accurately described.  
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Figure 1: Theoretical model illustrating the potential protective role of estrogen in 
skeletal muscle damage, inflammation, and repair. 
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In summary, clarifying the role of E2 during exercise induced muscle damage, 
inflammation, and repair is beneficial towards expanding this area of the research 
literature, as well as providing women with more information that may be potentially 
useful when designing training programs.  As demonstrated in this review, E2 plays a role 
in many physiological systems in addition to sexual and reproductive function.  
Understanding E2’s role in these systems, especially these systems involving exercise 
induced muscle damage, inflammation, and repair is especially important.  It has been 
suggested in this review that E2 may attenuate the inflammatory response, so that after 
exercise induced muscle damage enough cytokines are produced and leukocytes recruited 
to clear the damaged muscle tissues and limit excessive inflammation that may damage 
healthy muscle tissues.  The results of this study will contribute to this body of 
knowledge and provide insight as to the role of estrogen on inflammatory markers TNF-α 
and IL-6 after prolonged aerobic exercise. 
 
 24 
 
CHAPTER III 
METHODOLOGY 
 
 The recruited participants in this study made five visits to the Applied Physiology 
Laboratory at the University of North Carolina, Chapel Hill.  The first visit was an 
orientation visit, where informed consent was obtained, subjects were determined eligible 
for the study, descriptive characteristics were acquired, menstrual histories were recorded, 
and maximal oxygen consumption (VO2max) tests were completed.  The menstrual cycle 
was used to create two hormonal conditions, low E2  (LE) and high E2 (HE).  Participants 
reported to the investigator the first day of menses, which was denoted as day 1.  The LE 
phase occurs early in the menstrual cycle, roughly between days 3-7, when E2 is lower, 
while the HE phase occurs later, approximately between days 20-24, when E2 is much 
higher. Session two and four was an experimental protocol where subjects performed 60 
minutes of treadmill running at 65% of their predetermined VO2max in each hormonal 
condition, LE and HE.  The variables TNF-α, and IL-6 were measured at baseline, 
immediately post-exercise, 30 minutes post-exercise. E2 was measured at baseline. 
During session three and five, the days after the exercise protocol, the 24-hour post-
exercise blood draw was taken in each hormonal condition.  
Participants  
 Healthy, highly trained, pre-menopausal women between the ages of 18-30 years 
were recruited for this study.  Samples size was estimated from previous research in the 
literature to ensure adequate power (Appendix A). To be considered for this study, 
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participants were eumenorrheic for the past six months, had not taken oral contraceptives 
or other hormone therapy six months prior to participation, and were not currently taking 
anti-inflammatory medications for chronically diagnosed conditions, such as ibuprofen, 
naproxen, or aspirin.  Additionally participants had a current minimum training volume 
of 3-5 days a week, 45-120 minutes per session of aerobic activity, a VO2max of 45 
ml/kg/min, and no major injuries that limited the ability to engage in exercise. 
Participants that had sustained an injury in the past 6 months were fully recovered with a 
physician’s clearance for exercise before participating in the study.  Participants that 
became ill with a immune responding condition were dropped from the study.  Once 
cleared, participants signed informed consent after being thoroughly informed of the 
experimental protocol and any risks or rewards related to the study.  Additionally, 
participants agreed to abstain from strenuous physical activity and maintain a diet similar 
in calories and carbohydrate content for the 24 hours prior to the two experimental trials.  
Compliance was assessed through the use of a 24-hour food log and compliance 
questionnaire. Participants were asked to replicate their diet prior to each prolonged 
treadmill bout. 
Instrumentation  
Height was determined using a portable stadiometer (Perspectives Enterprises, 
Portage, MI USA).  Body mass was measured using a mechanical scale (Detecto, Webb 
City, MO USA).  Skinfolds were measured with a Lange skin caliper (Beta Technology, 
Inc., Santa Cruz, CA USA).  Maximal oxygen consumption was determined during a 
continuous, incremental treadmill test on a Quinton Q65 treadmill (Bothell, WA USA).  
Respiratory gases were obtained for the orientation session, as well as the two 
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experimental sessions using the Parvo Medics TrueMax 2400 Metabolic System (Parvo 
Medics, Salt Lake City, UT USA).  Heart rate was monitored continuously using the 
Polar telemetry system (Polar Electro, Inc., Lake Success, NY USA).  Ratings of 
perceived exertion were determined using Borg’s 20 point scale. Urine specific gravity 
was assessed using CLINITEK Atlas Automated Urine Chemistry Analyzer (Bayer, 
Erlangen, Germany).  Hematocrit was determined using an Adams MHCT II 
microhematocrit centrifuge (Becton Dickinson, Franklin Lakes, NJ USA) and an 
International Microcapillary Reader (International Equipment Company, Needham 
Heights, MA USA).  Hemoglobin was determined from a Stanbio Lab Hemopoint H
2
 
analyzer (Boerne, TX USA).  Whole blood samples were placed in an IEC Centra-8R 
refrigerated centrifuge (International Equipment Company, Needham Heights, MA USA) 
and the resultant separated plasma was stored and frozen at -80˚C.  Plasma TNF-α and 
IL-6 were measured using ABNOVA ELISA kits (Taipei, Taiwan).  Plasma E2 was 
measured using the radioactive (
125
I) immunoassay technique, (Siemens Healthcare 
Technologies, Los Angeles, CA USA).   
Protocol 
Pre-Screening 
 Women interested in participating in this study emailed the investigator. During 
this initial communication the investigator determined if they met the inclusion criteria.  
Women accepted into the study were scheduled for an orientation session.   
Orientation Session I 
 Participants arrived at the Applied Physiology Laboratory at The University of 
North Carolina, Chapel Hill and were informed of the experimental protocol, made aware 
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of the possible risks and rewards associated with the protocol, and signed an informed 
consent form (Appendix B). The Office of Human Research Ethics, Institutional Review 
Board, of The University of North Carolina, Chapel Hill approved the informed consent 
form.  After giving informed consent, participants underwent a physical screening and a 
12 lead electrocardiogram.  Then participants filled out the Exercise and Sports Science 
medical history questionnaire and passed the medical screening (Appendix C).  
Descriptive characteristics, such as height, weight, age and percent body fat were 
obtained.  Percent body fat was measured via measurements at the triceps, thigh, and 
suprailliac skinfolds, using the 3-site Jackson, Pollock, and Ward equation (Jackson et al., 
1980). 
 Next, participants completed a VO2max test using a continuous, incremental 
treadmill test.  They were allowed a five minute warm up consisting of running on the 
treadmill at their preferred pace, followed by light stretching.  Following the warm up, 
resting oxygen consumption VO2 was recorded for at least three minutes.  Participants 
then began the graded exercise test, as determined by the Bruce treadmill protocol 
(ACSM Guidelines, 2010).  Table 1 lists the Bruce protocol treadmill test. Throughout 
the test, heart rate (HR), 20 point scale ratings of perceived exertion (RPE), and 
respiratory gases were collected.  At the conclusion of the test, participants recovered 
(actively or passively) and were permitted to leave the laboratory when HR dropped 
below 100 beats per minute (bpm).  In order to confirm that the VO2 test was a maximal 
test (rather than a peak test) participants showed three of the four following criteria: a 
plateau or decrease in VO2 with increases in workload, respiratory exchange ratio (RER) 
greater than or equal to 1.1, RPE ≥ 18, and a HR within 10% of predicted heart rate max 
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(220-age, [ACSM Guidelines, 2010]). ACSM guidelines were used to estimate exercise 
intensity corresponding to 65% of VO2max, as shown in Appendix D (ACSM Guidelines, 
2010).  
 
Table 1: Speed (miles per hour; mph) and grade for each three minute stage of the Bruce 
protocol incremental exercise test.  
 
Stage Speed (mph) Grade (%) 
1 1.7 10 
2 2.5 12 
3 3.4 14 
4 4.2 16 
5 5.0 18 
6 5.5 20 
7 6.0 22 
 
Experimental Sessions II and IV  
Participants arrived at the Applied Physiology Laboratory once during the mid-
follicular (LE) phase of the menstrual cycle and once during the mid-luteal (HE) phase.  
The forward counting method (Chavanne & Gallup 1998) was used to determine and 
schedule sessions during the respective phases of the menstrual cycle. Participants 
reported to the investigator the first day of menses, this was denoted as day 1.  The LE 
phase occurs early in the menstrual cycle, roughly between days 3-7, when E2 is lower, 
while the HE phase occurs later, approximately between days 20-24, when E2 is much 
higher. The LE and HE phases of the menstrual cycle were used for the two experimental 
sessions to find the largest differences between naturally fluctuating E2 levels and 
maximize effect size. These date ranges are approximations, thus exact days in each cycle 
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varied as a result of the actual length of a subjects’ menstrual cycle and when they were 
scheduled for a testing session.  A menstrual cycle questionnaire was used to determine 
each participant’s respective phases of the menstrual cycle (Appendix E). The two 
experimental sessions were counterbalanced to prevent order effects.   
Subjects were asked to refrain from intense physical activity and replicated their 
diet 24 hours prior to each experimental session.  Subjects were asked if they followed all 
guidelines prior to the testing sessions, and a food diary was used to ensure nutrient 
intake was replicated between trials, as well as to make sure they consumed adequate 
calories and carbohydrate (Appendix F). To ensure adequate hydration, a urine sample 
was requested to assess urine specific gravity. If subjects were compliant, the 
experimental trial was continued. Subjects rested supine in a relaxed, quiet environment 
for 10 minutes.  After the resting period, blood was obtained (3mL) via individual blood 
draws.  The blood sample was placed in a sterile K2 –EDTA (purple top) Vacutainer™ 
tube and immediately put on ice.  Subjects then completed a five-minute warm-up 
consisting of cycling and stretching, followed by 60 minutes of running at their 
previously determined workload of 65% of VO2 max.  This intensity and time frame was 
chosen to make sure E2, IL-6 and TNF-α were elevated as a result of exercise (Bonen et 
al., 1979; Mendham et al., 2011; Pederson 2000).  During both treadmill bouts heart rate 
and VO2 was assessed at rest, while heart rate, ratings of perceived exertion, and VO2 was 
assessed from 6-10 minutes, 26-30 minutes, and 56-60 minutes.  This is shown in figure 2.  
During the first treadmill bout, at 10 and 30 minutes, VO2 was checked to ensure 
participants reached this intensity of 65%.  If participants were below 65%, the running 
speed was increased. This was not done in the second treadmill bout, because the running 
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trials were exactly replicated.  Immediately post exercise and 30 minutes into recovery, 
blood samples were taken (3mL) and promptly put on ice.  Plasma was separated from 
blood samples and stored until later analysis for E2, TNF-α, and IL-6.  Blood samples are 
stored for three years. 
Follow Up Blood Draws Session III and V 
 
 Participants returned to the APL 24 hours post exercise for additional blood draws.  
Upon entering the APL, participants laid supine, in a quiet environment, for 10 minutes.  
Blood samples were obtained to measure E2, TNF- α and IL-6 using the same procedures 
specified above. All data collection forms used are included in Appendix G. 
 
Figure 2: A diagram showing the protocol of the experimental sessions. 
 
 
 
 
Blood Procedures 
Hematocrit 
 Immediately post each exercise test, resting and post-exercise Hematocrit (Hct) 
values were determined in triplicate from whole blood samples.  Whole blood was put 
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into 75mm Allied Corporation microcapillary tubes (Fisher Scientific, Pittsburgh, PA) 
and sealed using Critoseal (Krackeler Scientific, Albany, NY).  Capillary tubes were spun 
in a microhematocrit centrifuge for three minutes at 10,000 RPM and then placed on a 
hematocrit wheel to determine the hematocrit values of each sample.  A mean was 
calculated from three samples and used in data analysis.   
Hemoglobin 
 
 Resting, immediately post-exercise, and recovery hemoglobin (Hb) values from 
each experimental session were measured in duplicate from the whole blood samples 
using the Stanbiolab Hemopoint H
2
 analyzer (Boerne, TX).  These values were 
determined immediately after completion of the exercise tests.  A mean was calculated 
from three samples and used in data analysis.   
Plasma Volume Shift 
Hb and Ht values were used to calculate exercise induced plasma volume shifts 
according to the Dill and Costill equation (Dill & Costill 1974).  
Cytokines (TNF-α and IL-6), E2 
 To separate plasma from whole blood, the blood samples were centrifuged at 
3,000 x g for 10 minutes.  The separated plasma was transferred to storage tubes and 
stored until analyses are conducted.  Radioactive (125I) immunoassay technique 
(Siemens Healthcare Technologies, Los Angeles, CA USA) with solid-phase antibody 
procedures was used to measure plasma E2 concentrations.  The assay manufacturer 
reports a minimum detectable concentration of 2.0 pg/mL.  High-sensitivity enzyme-
linked immunosorbent assay kits (Abnova, Taipei, Taiwan) were used to measure both 
TNF-α and IL-6.  The assay manufacturer reports a minimum detectable concentration of 
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5.0 pg/ml for TNF-α and 0.92 pg/mL for IL-6. All blood assays were performed in 
duplicate while standards were done in triplicate.  See Appendix H for assay sheets. 
 
Data Analysis 
 Statistica statistical software was used to analyze the data in this study (version 
6.3 Tulsa, OK USA).  Significance for all data was set at α < 0.05.   Descriptive statistics 
were shown as means ± standard deviations (SD).  Sample size of fifteen participants was 
estimated from previous research in the literature to ensure adequate power (=0.80).  
Effect size was calculated for all significant measures to determine if statistically 
significance effects had practical meaning.   
 Separate 2 x 4 (estradiol level x time) totally within, repeated measures ANOVAs 
and where appropriate, Bonferoni post hoc test, was used to assess the effects of estradiol 
on blood TNF-α and IL-6 concentrations.   
 At dependent t-test analysis was used to evaluate statistical significance between 
resting levels of estradiol--17 (E2) at LE and HE phase of each experimental session.   
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CHAPTER IV 
RESULTS 
Due to the stringency of the inclusion criteria and study protocol, only 10 of the 
15 initially recruited subjects completed all aspects the study.  Three subjects completed a 
VO2 max test, but did not meet the 45 ml/kg/min criteria.  One subject dropped out for 
personal health reasons.  One subject was not able to complete the treadmill bouts due to 
scheduling constraints.  The remaining 10 subjects met and maintained all of the 
inclusion criteria.  However, due to medical reasons, one subject was unable to complete 
the mid-luteal prolonged running bout.  In order to not lose this subject’s data within the 
statistical analysis, mean substitution was used to approximate their mid-luteal values.  
Additionally, several subject’s HR or RPE data were accidentally missed during data 
collection and this data was also approximated using mean substitution.    
Subject characteristics 
 As noted, ten eumenorrheic, aerobically trained females completed this study.  
These subjects met all the inclusion criteria: healthy females between the ages of 18-30 
years, eumenorrheic, not currently taking or have taken oral contraceptives or other 
hormone therapy 6 months prior to participation, have not had an injury in the previous 
six months, not currently taking anti-inflammatory medication, and have a current 
minimum training volume of 3-5 days per week, 45-120 minutes per session of aerobic 
activity and a VO2 max of at least 45 mL/kg/min.  Participant physical characteristics are 
reported in Table 2. 
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Table 2: Descriptive data for subjects. 
Measure Mean ± SD 
Age (yr) 21±1 
Height (cm) 164.5±5.7 
Body Mass (kg) 61.3±8.3 
Estimated Body Fat (%) 24.1±2.8 
 
VO2 peak testing 
 All the criteria for a maximal oxygen consumption test was not achieved by all 
subjects, thus all maximal oxygen consumption tests are referred to as VO2 peak tests.  
Average relative VO2 peak was 53.5 ± 4.7 ml/kg/min, while the average peak RPE 
obtained was 18 ± 1 Borg units, and the average peak HR was 191 ± 7 bpm.  The average 
calculated 65% of VO2 peak to use during the submaximal 60 minute prolonged runs was 
34.8 ± 3.0 ml/kg/min.   
Hormonal condition determination 
 Average menstrual cycle length of subjects was 28 ± 1 days.  Menstrual cycle 
condition was determined using the protocol detailed in the Methodology chapter.  With 
the onset of menses denoted day 1, subjects were tested on 7 ± 2 days during the mid-
follicular (low E2; LE) phase, while subjects were tested on 23 ± 3 days for the mid-luteal 
(high E2; HE) phase.  Analysis of resting blood samples for E2 indicated appropriate 
hormonal condition was achieved.    The LE concentration was 39.3 ± 18.3 pg/mL and 
the HE concentration was 148.1 ± 35.2 pg/mL.  These concentrations were significantly 
different from one another (p=0.003). The significant difference between hormonal 
conditions confirms the desired treatment effect was achieved. 
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Prolonged treadmill running bout  
Before each prolonged treadmill running bout, subjects submitted a 24 hour food 
log, and answered a questionnaire regarding compliance of pre-testing guidelines.  
Between the two testing sessions, all subjects complied with all guidelines (no strenuous 
exercise or consumption of anti-inflammatory medication, replication of dietary intake, 
and adequate consumption of fluids within 24 hours prior to the testing session).  Three 
subjects participated in light exercise within the 24 hour period prior to the first testing 
session, and this exercise was replicated exactly prior to the second prolonged running 
session.  The resting urine specific gravity was well below 1.030 cc
3
 for all subjects for 
both LE and HE prolonged running sessions, indicating adequate hydration prior to 
exercise.  Mean body mass prior to exercise for LE was 61.4 ± 8.6 kg and for HE was 
61.1 ± 8.3 kg; these values did not differ significantly (p>0.05).   
 Each prolonged running bout was performed for 60 minutes at the calculated 
running speed to elicit 65% of the individual’s VO2 peak.  All subjects were able to 
complete each of the 60 minute running bouts.  Actual treadmill running speed was 
replicated for each prolonged running bout, which was equal to 14.7 ± 1.3 km/hr with a 
corresponding VO2 of 61.7 ± 5.0% during LE and 59.7 ± 2.8% during HE.  The 
prolonged running sessions were counterbalanced in order to prevent order balances, six 
subjects completed LE then HE, while four subjects completed HE before LE.  The mean 
VO2, HR and RPE were nearly identical for each of the 60 minute running sessions.  
Descriptive data at each measurement time is shown in Table 3 below.  
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Table 3: Descriptive data (mean ± SD) for VO2, HR and RPE for each prolonged running 
bouts in each hormonal condition (LE and HE). 
 
Hormonal 
Condition 
Measure 
Time (min) 
Rest 10 30 60 
LE 
VO2  
(mL/kg/min) 
4.9±0.6  30.4±4.2 33.2±3.2 35.2±2.9 
HR  
(bpm) 
63±7 150±15 157±13 165±13 
RPE  
(Borg units) 
 
- 11±1 12±1 14±1 
HE 
 
VO2 
(mL/kg/min) 
4.9±0.4  30.0±3.2 32.7±3.3 33.1±4.5 
HR  
(bpm) 
61±4 149±7 154±6 164±6 
RPE  
(Borg units) 
- 11±1 12±1 14±2 
 
Using the Dill and Costill method of determining plasma volume shifts, plasma volume 
decreased over the prolonged running bouts were calculated.  These plasma volume shifts 
are reported in Table 4.    
 
Table 4: Mean (± SD) plasma volume shifts from rest to immediately post exercise (R-IP), 
rest to 30 minutes post exercise (R-30P) and rest to 24 hours post exercise (R-24P). 
 
Hormonal 
Condition 
Plasma Volume Shift (%) 
R-IP R-30P R-24P 
LE -8.5±6.9 -3.1±8.0 6.6±16.1 
HE -8.1±5.9 -8.6±7.6 -2.6±6.8 
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Blood responses to prolonged exercise   
Tumor necrosis factor-α (TNF-α) 
TNF- responses are reported in Table 5.  The main effect for hormonal condition 
was not significant (p=0.48).  The main effect for time was significant (p=0.001), with 
post-hoc tests indicating there was a significant increase from rest to 30 minutes post 
exercise (p=0.001), from rest to 24 hours post exercise (p=0.001), and from immediately 
post exercise to 24 hours post exercise (p=0.03).  There was not a significant interaction 
effect for hormonal condition and time (p=0.60).  
Interleukin-6 (IL-6) 
 Interleukin-6 responses are reported in Table 6.  The main effect for hormonal 
condition was significant (p = 0.022), with post hoc revealing IL-6 response was greater 
in LE than HE.  The main effect for time was also significant (p=0.001), with IL-6 
elevated from rest to immediately post exercise, and from rest to 30 minutes post exercise.  
There was a significant interaction effect between hormonal condition and time for IL-6 
(p=0.001).  Post hoc revealed that IL-6 was significantly increased from rest to 
immediately post exercise, and from rest to 30 minutes post exercise in both hormonal 
conditions.  The response at immediately post exercise did not differ between LE and HE, 
however, the response at 30 minutes post exercise was significantly elevated in LE when 
compared to HE (p=0.002).    
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Table 5: Mean (± SD) for TNF- at rest, immediately post exercise (IP), 30 minutes post 
exercise (30P), and 24 hours post exercise (24P). An * indicates significant increase from 
rest, while an ^ indicates significant increase from IP.   
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Table 6: Mean (± SD) for IL-6 at rest, immediately post exercise (IP), 30 minutes post 
exercise (30P), and 24 hours post exercise (24P). An * indicates significance from rest, 
an ^ indicates significantly lower IL-6 compared to LE, while a # indicates an interaction 
effect between hormonal condition and time.   
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CHAPTER V 
DISCUSSION 
The purpose of this study was to determine if circulating E2 levels influenced the 
pro-inflammatory cytokine biomarker TNF- responses in the blood, following a 
moderate intensity prolonged exercise session in eumenorrheic women.  A secondary 
purpose of this study was to determine if E2 levels influenced the cytokine biomarker IL-
6 (both a pro- or anti-inflammatory) response in the blood, following a moderate intensity 
prolonged exercise session in eumenorrheic women.  It was hypothesized that higher E2 
levels would attenuate both TNF- and IL-6 responses after the exercise bout.  To test 
these hypotheses, ten aerobically trained, eumenorrheic women completed 60 minute 
treadmill bouts in a LE condition and again in a HE condition, with blood collection 
occurring at rest, immediately post exercise, 30 minutes post exercise, and 24 hours post 
exercise.   
Hormonal condition determination 
 In this study, there was a significant treatment condition between the LE and HE 
menstrual cycle conditions (p=0.003), with an approximately four times greater increase 
in E2 from LE to HE (39.3 ± 18.3 pg/ml to 148.1 ± 35.2 pg/ml, respectively). These 
results fell within expected values determined by the ELISA kit used in analysis; as mid-
follicular (LE) levels were reported to range from 30-100 pg/ml and mid-luteal (HE) 
levels were reported to range from 60-400 pg/ml (Human E2, Abnova, Walnut, CA).  The 
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existence of a significant treatment condition is in alignment with other studies 
investigating the effect of E2 on inflammatory markers (Chiu et al., 2000; Hackney et al., 
1991; Northoff et al., 2008).   
Prolonged aerobic exercise session 
The physiological responses (results in Table 3) to the 60 minute the treadmill 
running bouts confirm the experimental sessions were closely replicated.  That is, the 
results show that VO2, HR, and RPE responses were similar between bouts. Furthermore, 
actual running speed in each session was replicated exactly and corresponded to an 
average VO2 of 61.7 ± 5.0% during LE and 59.7 ± 2.8% during HE. While this elicited 
VO2 was below the prescribed 65% of VO2peak desired, this intensity has been shown in 
previous research done by this laboratory to elicit suitable muscle damage to initiate 
inflammation (Hackney et al., 2012). With the physiological markers confirming that 
there was very little difference between 60 minute testing sessions, it is concluded that 
any differences in blood measured cytokine responses to the exercise resulted primarily 
from fluctuating E2 across the menstrual cycle. 
Plasma volume values indicate that plasma fluid left the vascular bed from rest to 
immediately post exercise and from rest to 30 minutes post exercise during LE (-8.5 ± 
6.9% and -3.1 ± 8.0%, respectively) and during HE (-8.1 ± 5.9% and -8.6 ± 7.6%, 
respectively).  This hemoconcentration of the blood is most likely indicative of slight 
exercise induced dehydration (Dill & Costill, 1974).   From rest to 24 hours post exercise, 
the plasma volume shift was positive during LE (+6.6 ± 16.1%) and slightly negative 
during HE (-2.6 ± 6.8%) indicating the subjects may have rehydrated well and plasma 
volume was closer to normal values, respectively.   The percent changes in the blood 
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measured responses of TNF- and IL-6 were much larger than the plasma volume shifts, 
indicating that the changes in these outcome variables were indicative of increased 
production level and thus an inflammatory response and not hemoconcentration or 
hemodilution induced changes.   
Blood responses  
Tumor Necrosis Factor (TNF-α) 
 There was a significant main effect for time with post hoc tests indicating that 
there was a significant increase from rest to 30 minutes post exercise, from rest to 24 
hours post exercise and from immediately post exercise to 24 hours post exercise.  These 
results are in line with other previous research, suggesting that there is an acute 
inflammatory response, mediated by the pro-inflammatory cytokine TNF-, after 
exercise induced muscle damage (Ostrowski et al., 1999; Pederson et al., 2000: Smith et 
al., 2000).   The concentrations of TNF- reported in this study are in line with the 
concentrations reported in one other study (Ostrowski et al., 1999).  Specifically, 
Ostrowski et al. reported TNF- values significantly increase in males after a marathon, 
and these values stayed elevated for up to 1.5 hours post exercise.  The significant 
increase in TNF- complements the current study, which suggests that TNF- followed 
the same response in women after a much shorter exercise intervention.   
In the current study there was not an interaction effect for TNF- for hormonal 
condition by time.  The comparative literature is limited in the number of investigations, 
which have studied the effects of E2 on TNF-, hence this is why the present study was 
conducted.   Those available studies have shown an effect of fluctuating E2 on TNF- at 
rest (Schwarz et al., 1990), and in endotoxin models (Chao et al., 1995; Puder et al., 
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2001). Schwarz et al., found that TNF- was attenuated during HE when compared to LE.  
Puder et al., suggests that high concentrations of E2 can limit the inflammatory response, 
with the reduction of circulating TNF-.   Lastly, Chao et al., proposes that E2 greatly 
regulates the release of TNF-, with very high and low physiological levels of E2 
attenuating TNF- and mid-physiological concentrations of E2 increasing TNF-.    
While it has been shown in these few select studies that E2 does affect TNF-, there may 
not be as large of an effect following an exercise intervention to be physiologically 
detectable; which this study supports.  Additionally, the sample size was not adequately 
powered to see significance for TNF- (=0.68; i.e., underpowered). However it is un-
likely significance would have occurred with 15 subjects, because the largest mean 
difference (TNF-α response at 24 hours post exercise) would have required a sample size 
of 55 subjects to reach significance.      
Interleukin-6 (IL-6) 
There was a main effect for both hormonal condition and time, and an interaction 
effect for hormonal condition by time.  Post hoc testing revealed that IL-6 was 
significantly increased from rest to immediately post exercise, and from rest to 30 
minutes post exercise in both hormonal conditions.  The response immediately post 
exercise did not differ between LE and HE; however, the response at 30 minutes post 
exercise was significantly greater in LE condition when compared to HE.  The practical 
significance of these findings, as shown by the effect size, was large (Cohen d statistic = 
1.135).  This suggests that there is a strong relationship between E2 and IL-6 and the 
results are meaningful.   
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The results of this study are in line with the results of previous research produced 
in our laboratory where E2 was found to attenuate IL-6 immediately post exercise and 30 
minutes post exercise (Hackney et al., 2012).  These results are also in line with studies 
investigating the effect of E2 on IL-6 at rest (Angstwurm et al., 1997; Chiu et al., 2000; 
Schwarz et al., 2000).  Interestingly, and somewhat in contradiction to the current study, 
Northoff et al., found HE facilitates up-regulation of TNF- genes and down-regulation 
of IL-6 genes, suggesting higher E2 levels influences a pro-inflammatory environment.  
This study was set up very similarly to the current study, with the measurement of TNF- 
and IL-6 occurring after a high intensity (~93% of anaerobic threshold) exercise bout.  
Other studies, however, indicate that there is a weak or non-existent relationship between 
E2 and IL-6.  Ives et al., found E2 to be unrelated to IL-6 at rest or in response to exercise.  
These results of Ives et al. should be interpreted with caution, however, because there 
was not a treatment effect (LE was not significantly different from HE). Considering the 
differing results regarding the estrogenic effect on inflammation, it is hard to know for 
certain how or if E2 exerts a strong influence on IL-6. The current results suggest there is 
an effect; nonetheless, more research is warranted 
It is well documented that IL-6 increases dramatically with exercise (Brenner et 
al., 1999; Edwards et al., 2006; Ives et al., 2011; Ostrowski et al., 1998).  IL-6 is a unique 
cytokine because of its both pro- and anti-inflammatory effects.  Recent investigations 
suggest IL-6 is released locally from the skeletal muscle after an acute exercise bout, with 
the amount released dependent on the type of physical activity and the duration of the 
exercise (Hamer & Karageorghis. 2007).  This acute IL-6 released is thought to have 
primarily anti-inflammatory cytokine effects, such as the inhibition of pro-inflammatory 
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TNF- (Febbraio et al., 2002; Pederson et al., 2003; Schwarz et al., 2000). The acute IL-
6 response is also thought to have myokine effects such as the stimulation of lipolysis and 
fat oxidation to aid in the maintenance of glucose metabolism (Ives et al., 2011).   In the 
context of this study, the attenuation of IL-6 may be considered negative because there is 
less IL-6 exerting anti-inflammatory and glucose sparing effects or it may be considered 
positive because there is overall less inflammation due to the protective effects of E2. 
Further work is necessary to address this paradox.    
The mechanism by which E2 exerts a protective effect on skeletal muscle and 
inflammation is not well understood, but thought to be a result of E2 acting as an 
antioxidant, membrane stabilizer and gene regulator (Perksy et al., 1999).  While it can be 
interpreted that there is less IL-6 exerting anti-inflammatory and glucose sparing effects 
during HE, a bulk of the research literature suggests that the attenuation of IL-6 is 
positive because it means there is less overall inflammation following damaging exercise 
(Angstwurm et al., 1997; Chiu et al., 2000; Schwarz et al., 2000).  Additionally previous 
research in this laboratory, found HE concentrations to promote glucose-sparing 
mechanisms and increase fat utilization by increasing the activity of lipoprotein lipase, 
circulating growth hormone, and decreasing circulating insulin levels (Hackney et al., 
1999).  This supports the theory that HE levels promote fat utilization and the attenuation 
of IL-6 may result from less muscle damage and inflammation following the exercise 
bout and less of a need for IL-6 as enhancer of lipolysis since HE may be exerting some 
of these actions directly.  Additionally, previous research has shown that there is less 
muscle damage following an exercise intervention during HE concentrations (Carter et al., 
2001).  This also suggests that the attenuation of IL-6 is positive, indicating that there is 
 46 
less potential overall inflammation following the exercise bout, less collateral damage to 
healthy skeletal muscle tissue and less muscle soreness. While there is uncertainty 
regarding the exact mechanistic influence of IL-6, future research is needed to fully 
elucidate the role of E2 as it fluctuates across the menstrual cycle and inflammation after 
a moderate intensity aerobic exercise bout.       
The inability to determine whether pro- and anti-inflammatory IL-6 exerts a 
positive or negative influence on skeletal muscle after exercise-induced muscle damage 
was a major limitation of this study.  Other limitations include a small sample size.  
While the sample size was adequate to see a meaningful significance between hormonal 
condition and IL-6, the sample size was not adequately powered to see significance for 
TNF- (=0.65; i.e., underpowered).   In order to see significance, additional subjects 
needed to be recruited.  Additionally, results are only applicable to eumenorrheic women 
because post-menopausal, amenorrheic, oligomenorrheic, and oral contraceptives users 
have different hormonal profiles, which alters their inflammatory response to exercise.     
Due to the pro- and anti-inflammatory actions of IL-6, and the uncertainty in the 
literature as to how IL-6 exerts its influence with respect to E2 after muscle damaging 
exercise, there is great need to conduct more research in this area.  Recommendations for 
future research include clarifying the role of E2 and its effect on inflammation after 
exercise induced muscle damage, as well as clarifying the role of IL-6.  In order to 
determine a more comprehensive understanding of the effect of E2 on the immune 
response, additional cytokines needed to be investigated, both pro- and anti-inflammatory, 
in order to elucidate whether there is an estrogenic effect after exercise.  Future research 
should also investigate whether there is a possibility of interaction between E2 and 
 47 
progesterone on the immune response following exercise, since both of these hormones 
fluctuate across the menstrual cycle.   
In conclusion, there was not a significant interaction effect between E2 and the 
cytokine TNF-, indicating that HE does not attenuate pro-inflammatory TNF- 
responses.  However, there was a significant interaction effect between E2 and IL-6, the 
significance of this finding is unclear due to the pro- and anti-inflammatory effects of IL-
6.   Other known pro-inflammatory markers should also be looked at to determine if there 
is in fact a protective influence of E2 on muscle damage, inflammation, and repair.  
Information regarding the estrogenic effect on inflammation across the menstrual cycle 
would be useful for eumenorrheic women not on birth control, when designing exercise 
programs, as well as considerations in study design when investigating the inflammatory 
response in women.   
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APPENDIX A 
SAMPLE SIZE CALCUATIONS 
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APPENDIX B 
INFORMED CONSENT  
University of North Carolina at Chapel Hill 
Consent to Participate in a Research Study 
Adult Participants 
 
Consent Form Version Date: __2013-2014____________ 
IRB Study # 10-2109 
Title of Study: Influence of Estrogen on Cytokine Response to Prolonged Treadmill Running 
Principal Investigator: Anthony Hackney 
Principal Investigator Department: Exercise And Sport Science 
Principal Investigator Phone number: (919) 962-0334 
Principal Investigator Email Address: ach@email.unc.edu 
_________________________________________________________________ 
 
What are some general things you should know about research studies? 
You are being asked to take part in a research study.  To join the study is voluntary. 
You may refuse to join, or you may withdraw your consent to be in the study, for any reason, without 
penalty. 
 
Research studies are designed to obtain new knowledge. This new information may help people in the 
future.   You may not receive any direct benefit from being in the research study. There also may be risks to 
being in research studies. Deciding not to be in the study or leaving the study before it is done will not 
affect your relationship with the researcher, your health care provider, or the University of North Carolina-
Chapel Hill. If you are a patient with an illness, you do not have to be in the research study in order to 
receive health care. 
 
Details about this study are discussed below.  It is important that you understand this information so that 
you can make an informed choice about being in this research study.  
 
You will be given a copy of this consent form.  You should ask the researchers named above, or staff 
members who may assist them, any questions you have about this study at any time. 
 
What is the purpose of this study? 
Recent work has shown a negative relationship between concentration of estrogens and the inflammatory 
response, specifically cytokines, at rest. Females in the midluteal phase of the menstrual cycle, high 
estrogen concentration, exhibited significantly lower circulating cytokines (and creatine kinase) compared 
to females in the midfollicular phase, low estrogen concentration. These demonstrated fluctuations at rest 
begs the question - Is there an altered cytokine response during exercise at different points within the 
menstrual cycle as estrogen changes? 
  
To date, few exercise studies on human female subjects with respect to estrogen concentration and 
cytokines exist. The studies that do exist present divergent results. The studies performed have limitations; 
primarily small sample sizes, potential inaccurate menstrual phase determination, or dosage of exercise was 
not enough to provoke a response. 
  
The purpose of this research study is to learn about the influence estrogen has on the cytokine response to 
prolonged treadmill running. The results of this study will add to the limited body of knowledge available 
on the influence of estrogen on cytokine expression in response to exercise within women, potentially 
providing insight as to how training regimens might be altered for optimal performance and minimal risk. 
  
The main aim of the study is to determine if there is a significant difference in cytokine response at rest, 
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immediately post exercise, 30 minutes post exercise, and 24 hours post exercise between two phases of the 
menstrual cycle, midluteal and midfollicular. On separate days, you will perform an exercise test on a 
treadmill to determine your maximal aerobic capacity (VO2max), two 60-minute running bouts at 
approximately 65-70% VO2max, and have blood drawn before, immediately post, 30 minutes post, and 24-
hours post the 60-minute running bout. Blood samples will be assessed for estrogen and cytokine 
concentration and creating kinase levels.  
  
You are being asked to be in the study because you are a healthy, highly trained woman between the ages 
of 18 and 30 with a normal menstrual cycle for at least 6 months. You have not used oral contraceptives for 
at least six months prior. Have no major injuries within the last six months that limit ability to engage in 
exercise or if have sustained an injury are completely recovered and cleared by a physician to partake in 
exercise. Your current VO2max is at least 45 ml/kg/min. Your current minimum training volume is 3-5 
days a week, 45-120 minutes per session of aerobic activity. 
 
Are there any reasons you should not be in this study? 
You should not be in this study if you are knowingly pregnant or become pregnant during the study, if you 
have an irregular or absent menstrual cycle, are currently taking or have taken within the six months prior 
oral contraceptives, you have sustained an injury within the last six months that has limited your ability to 
exercise, use substances known to alter immune response (e.g. NSAIDS) the week before each 60-minute 
exercise session, or you become ill with immune responding conditions (i.e., colds, respiratory 
infections…etc.). 
 
How many people will take part in this study? 
There will be approximately 25 people in this research study. 
 
How long will your part in this study last? 
You will be enrolled in the study for approximately 6 weeks. Within the 6 weeks, 3 visits are made to the 
Applied Physiology Laboratory at the University of North Carolina at Chapel Hill. 
 Visit 1: Orientation Session, duration is approximately 90 minutes 
 Visit 2 (approximately 1-6 weeks after visit 1): Prolonged treadmill running bout (60 min)  with a 
before and immediately, and 30 minutes after exercise blood draws performed by a certified 
phlebotomist (NCPT 56147) visit, duration is approximately 2 hours 
 Visit 3: 24-hours after prolonged running bout blood draw, duration is approximately 30 minutes 
Visits 4-5 will be a repeat of visits 2-3 approximately 2-6 weeks after visit 2. Blood specimens will be 
stored for 3 years following the completion of the study. 
What will happen if you take part in the study? 
Orientation/Familiarization Session, duration approximately 90 minutes (visit 1): 
  
 The study protocol, schedule, inherent benefits, and potential risks will be explained to you, 
followed by signing the informed consent. 
 You will go through a physical screening that includes completing the Department of Exercise & 
Sport Science (EXSS) medical history questionnaire and undergoing a physical examination and 
12-lead electrocardiogram in the Applied Physiology Laboratory. The physical examination 
includes auscultation of blood pressure, review of heart sounds, and pulmonary assessment. The 
physical examination and 12-lead electrocardiogram will be conducted and assessed by approved 
personnel. 
 Height and mass will be obtained and you will be fitted for a heart rate monitor and then asked to 
rest lying down for 10 minutes. After obtaining your resting heart rate, you will be fitted for a 
mouthpiece that will be used to collect expired air. 
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 You will then perform a modified Bruce Protocol to volitional fatigue to determine VO2max. The 
protocol consists of 3-minute stages with progressive speed at 0% inclined to near max, then grade 
will be introduced to maximal exertion (e.g. 3 minutes: 6.0, 0%, 3 minutes: 7.5, 0%, 3 
minutes:  9.0, 0%, 3 minutes, 9.0, 2.5%). Heart rate (HR), rating of perceived exertion (RPE), and 
expired air will be monitored throughout the test. VO2max attained will be used to determine 
running speed for the specific menstrual phase prolonged running bout for each individual subject. 
Menstrual Phase Determination: 
  
You will need to inform the principal investigator at the start of menses (the first menses following visit 1 
to the lab), which will be denoted as day one. Scheduling of the prolonged treadmill running bout will 
correspond to a specific menstrual phase. 
  
Prolonged treadmill running bout 1, duration approximately 2 hours (Visit 2 and 4): 
  
The time lapse between visit 1 and visit 2 is not determined by investigators, rather it is determined based 
upon your menstrual cycle. The start of your menstrual cycle (e.g. menses, day 1) and the approximate 
length of your menstrual cycle (day 1 of menses to the start of the next menses) will determine when you 
are scheduled for the prolonged running bouts so as to ensure you are in the appropriate menstrual cycle 
phase. The approximate time between visit 1 and visit 2 can be 1-6 weeks. Between visit 1 and 24-hours 
before visit 2 you can partake in normal daily activities and exercise training with no restrictions. Twenty-
four hours prior to the prolonged running bout you will be asked to refrain from exercise, drink plenty of 
fluids, and eat a diet rich in carbohydrates. 
 Upon arrival, you will be asked to urinate into a sterile specimen container. The urine will be 
assessed for hydration status. If the urine analysis comes back as dehydrated you will not 
participate in the prolonged running bout, you will be encouraged to consume plenty of fluids, and 
you will be rescheduled. 
 If the urine analysis comes back normal you will be weighed, fitted with a HR monitor, and asked 
to rest lying down for 10 minutes. After, a resting HR will be recorded and a 1-teaspoon blood 
sample will be drawn from your arm by a certified phlebotomist (NCPT 56147), placed into a K3-
EDTA blood collection tube and immediately put on ice. The blood sample will be used to 
confirm menstrual cycle status and resting IL-6, and estrogen levels. 
 You will then be transferred to the treadmill and fitted for a mouthpiece. You will be asked to sit 
quietly for 4 minutes as your expired air is collected to determine resting VO2. 
 You will then have 10 minutes to warm-up: 5 minutes will be dedicated to easy walking on the 
treadmill followed by 5 minutes of stretching appropriate muscles used in the upcoming prolonged 
running bout (e.g. calf stretch, hamstring stretch, quadriceps stretch, and hip flexor stretch). 
During the walking, you will practice going on and off the mouthpiece as you are moving. 
 Following warm-up, you will run on a treadmill at a 0% incline and a speed to elicit 65-70% 
VO2max. At 6 minutes, 26 minutes, and 56 minutes you will be asked to return to the mouthpiece 
and expired air will be recorded for four minutes. This is to ensure appropriate intensity and make 
adjustments in running speed if necessary. Heart rate and RPE will be recorded during the last 10 
seconds of minutes 9, 29, and 59 of the running bout. 
 Throughout the running bout you will have a fan to keep you cool, can drink water at your 
convenience, and listen to music. 
 At the completion of exercise, another 1-teaspoon blood sample will be drawn following the same 
procedure, placed in K3-EDTA blood collection tube, and immediately placed on ice. This blood 
sample will be analyzed for IL-6 and estrogen concentrations. After blood collection you will cool 
down. The cool down will consist of walking on the treadmill at an easy pace for 5 minutes, 
stretching muscles used during the prolonged running bout (e.g. calf stretch, hamstring stretch, 
quadriceps stretch, and hip flexor stretch), and sitting quietly in a chair. 
 30 minute post blood draw 
 Once your heart rate has returned to 100 bpm you are free to leave the laboratory. 
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Follow-up Blood Draws, duration approximately 30 minutes: 
  
At 24 hours after the running bout you will report to the laboratory for additional blood draws. You will be 
asked to rest lying down for 10 minutes. Blood samples will be obtained following the same blood draw 
procedures as explained above. These blood samples will be analyzed for IL-6 and estrogen concentrations. 
During the 24 hours of recovery from the exercise you are asked to refrain from performing any physical 
activity other than that of daily routine living. 
  
Prolonged treadmill running bout, duration approximately 2 hours: 
  
You will be asked to repeat the aforementioned protocol during two different phases of your menstrual 
cycle. The time frame between the prolonged running bouts is approximately 2 to 6 weeks. Between visit 4 
and 24-hours before visit 5 you can partake in normal daily activities and exercise training with no 
restrictions. 
  
Blood Analysis: 
  
The blood samples will be separated by centrifuging and frozen until later analysis. The blood plasma will 
be analyzed for estrogen levels, creatine kinase and immune markers. 
What are the possible benefits from being in this study? 
Research is designed to benefit society by gaining new knowledge.  There is little chance you will benefit 
from being in this research study. The benefits to you from being in this study may be the obtaining of your 
Vo2max (aerobic capacity) which you can use in setting up a specific exercise training program. 
 
What are the possible risks or discomforts involved from being in this study? 
The potential risks to you from participating in this study may be related to exercise or the blood draw 
process. 
  
Potential risks associated with exercise are outlined by American College of Sports Medicine as: sudden 
cardiac death, musculoskeletal injury, and falling. 
 The risk of sudden cardiac death is low in healthy individuals; however, to minimize risk a health 
history questionnaire and physical examination will occur prior to testing. 
 To minimize risk of musculoskeletal injury a proper warm-up will be completed prior to all testing. 
 Given the prolonged nature of the exercise bout dehydration is a potential risk. To minimize this 
risk your hydration status will be determined before testing begins ensuring you are in normal 
hydrated state; if dehydrated the testing session will be cancelled and rescheduled. You will be 
asked to consume plenty of fluids 24 hours before testing and encouraged to drink water 
throughout and after the running bout. 
 The universal sign for stopping an exercise session will be explained to you prior to all testing 
sessions. Research technicians will closely monitor your status during the exercise sessions for 
signs and symptoms of fatigue or a cardiac event to reduce risk of injury or falling. 
Furthermore, the potential risk of exercise for you will be minimal because you have performed similar 
exercise intensities and durations within previous training programs. 
  
Risks associated with blood draws include infection, bruising of the area around the needle insertion, and 
dizziness/fainting. 
 To minimize infection, cleaning of the puncture area and sterile equipment will be used. 
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 Proper needle gauge and firm pressure applied to the puncture following the blood draw will help 
minimize risk of bruising. 
 Following the blood draw, to minimize the risk of syncope you will be asked to move from a 
supine position to sitting and eventually standing slowly. Research technicians will monitor 
complexion and skin temperature for adverse signs. 
A certified phlebotomist will perform all blood draws. First aid procedures and universal precautions will 
be followed during blood draws and handling of blood samples. 
There may be uncommon or previously unknown risks. You should report any problems to the researcher. 
 
What if we learn about new findings or information during the study?  
You will be given any new information gained during the course of the study that might affect your 
willingness to continue your participation.  
 
How will information about you be protected? 
Following initial screening, an identification number will be assigned to you for future identification. A 
hard copy of records will be stored in a locked cabinet in the Applied Physiology Laboratory.  Electronic 
records will be maintained on a secured, password-protected computer. All identifiable hard-copy files will 
be shredded and disposed of using UNC-CH mechanisms and procedures. Blood samples will be stored in a 
secured ultra-freezer behind a access code protected door within a laboratory involving only electric ID 
card access. These specimens will be encoded and labeled so that no personal identifying information will 
be revealed. The identification number will consist of a unique number along with phase and the sample 
time (e.g. 00913, 009 is the subject ID, 1 is indicative of menstrual phase, 3 is time sample). Study data and 
specimens will only contain the identification number. These numbers will be indiscernible unless access to 
the master list which will be locked in a file cabinet in the Applied Physiology Laboratory. Only the 
principal investigator will have access to the records. 
 
Participants will not be identified in any report or publication about this study. Although every effort will 
be made to keep research records private, there may be times when federal or state law requires the 
disclosure of such records, including personal information.  This is very unlikely, but if disclosure is ever 
required, UNC-Chapel Hill will take steps allowable by law to protect the privacy of personal 
information.  In some cases, your information in this research study could be reviewed by representatives 
of the University, research sponsors, or government agencies (for example, the FDA) for purposes such as 
quality control or safety. 
 
What will happen if you are injured by this research? 
All research involves a chance that something bad might happen to you.  This may include the risk of 
personal injury. In spite of all safety measures, you might develop a reaction or injury from being in this 
study. If such problems occur, the researchers will help you get medical care, but any costs for the medical 
care will be billed to you and/or your insurance company. The University of North Carolina at Chapel Hill 
has not set aside funds to pay you for any such reactions or injuries, or for the related medical care. You do 
not give up any of your legal rights by signing this form. 
 
What if you want to stop before your part in the study is complete? 
You can withdraw from this study at any time, without penalty.  The investigators also have the right to 
stop your participation at any time. This could be because you have had an unexpected reaction, or have 
failed to follow instructions, or because the entire study has been stopped. 
 
Will you receive anything for being in this study? 
You will not receive anything for taking part in this study. 
 
Will it cost you anything to be in this study? 
It will not cost you anything to be in this study.  
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What if you are a UNC student? 
You may choose not to be in the study or to stop being in the study before it is over at any time.  This will 
not affect your class standing or grades at UNC-Chapel Hill.  You will not be offered or receive any special 
consideration if you take part in this research. 
 
What if you have questions about this study? 
You have the right to ask, and have answered, any questions you may have about this research. If you have 
questions about the study (including payments), complaints, concerns, or if a research-related injury occurs, 
you should contact the researchers listed on the first page of this form. 
 
What if you have questions about your rights as a research participant? 
All research on human volunteers is reviewed by a committee that works to protect your rights and 
welfare.  If you have questions or concerns about your rights as a research subject, or if you would like to 
obtain information or offer input, you may contact the Institutional Review Board at 919-966-3113 or by 
email to IRB_subjects@unc.edu. 
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Participant’s Agreement: 
 
I have read the information provided above.  I have asked all the questions I have at this time.  I voluntarily 
agree to participate in this research study. 
  
 
______________________________________________________ 
Signature of Research Participant 
 
____________________ 
Date 
 
______________________________________________________ 
Printed Name of Research Participant 
  
  
 
______________________________________________________ 
Signature of Research Team Member Obtaining Consent 
 
____________________ 
Date 
 
______________________________________________________ 
Printed Name of Research Team Member Obtaining Consent 
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APPENDIX C 
MEDICAL SREENING FORMS 
 
Physical Examination Screening 
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Medical History Questionnaire  
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 61 
 
APPENDIX D 
ACSM METABOLIC EQUATION FOR DETERMINING EXERCISE INTENSITY 
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APPENDIX E 
MENSTRUAL CYCLE QUESTIONNAIRE 
 
 63 
APPENDIX F 
FOOD LOG 
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APPENDIX G 
DATA COLLECTIONS FORM 
Orientation Session 
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Experimental Session 
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Hematocrit and Hemoglobin 
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Subject Compliance  
Have you had anything to eat or drink, besides water, within the last two hours?  
 
Yes                     No 
 
Have you had any anti-inflammatory drugs (Advil, Tylenol, etc) within the last 24 
hours? 
 
Yes                     No 
 
Have you participated in any strenuous exercise within the last 24 hours? 
 
Yes                     No 
 
Have you had any caffeine or alcohol within the last 24 hours? 
 
Yes                     No 
 
Do you have your diet log? (make a copy and give back to subject) 
 
Yes                     No 
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APPENDIX H 
ASSAY SHEETS 
 
Estrogen Assay Information  
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TNF- Assay Information  
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IL-6 Assay Information  
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